Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and Endocrinologists
出版年份 2021 全文链接
标题
Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and Endocrinologists
作者
关键词
SGLT2 inhibitors, Primary care, Type 2 diabetes, Cardiovascular, Education, Qualitative study
出版物
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 180, Issue -, Pages 109036
出版商
Elsevier BV
发表日期
2021-09-02
DOI
10.1016/j.diabres.2021.109036
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prescribing in Type 2 Diabetes Patients With and Without Cardiovascular Disease History: a Descriptive Analysis in the UK CPRD
- (2021) Ruth E. Farmer et al. CLINICAL THERAPEUTICS
- Impact on guidelines: the general practitioner point of view
- (2020) X. Cos et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Primary Care Physicians’ Knowledge of the Cardiovascular Effects of Diabetes Medications: Findings from an Online Survey
- (2020) Jay H. Shubrook et al. ADVANCES IN THERAPY
- Barriers to prescribing glucose-lowering therapies with cardiometabolic benefits
- (2020) Yumin Gao et al. AMERICAN HEART JOURNAL
- The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study
- (2020) Jedidiah I. Morton et al. DIABETOLOGIA
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Global survey investigating causes of treatment inertia in type 2 diabetes cardiorenal risk management
- (2020) Naresh Kanumilli et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and the Effect of Empagliflozin on Kidney Outcomes in Type 2 Diabetes: An Analysis From the EMPA-REG OUTCOME Trial
- (2019) Mark E. Cooper et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c
- (2019) Christopher P. Cannon et al. CIRCULATION
- Drug promotion practices: A review
- (2018) Nilan T. Jacob BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of the Canadian Diabetes Association guideline dissemination strategy on clinician knowledge and behaviour change outcomes
- (2018) Catherine H. Yu et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The future of continuing medical education: the roles of medical professional societies and the health care industry
- (2018) et al. EUROPEAN HEART JOURNAL
- Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control
- (2018) Silvio E. Inzucchi et al. CIRCULATION
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Barriers to effective management of type 2 diabetes in primary care: qualitative systematic review
- (2016) Bruno Rushforth et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now